{"id":2669,"date":"2021-10-18T08:42:45","date_gmt":"2021-10-18T06:42:45","guid":{"rendered":"https:\/\/www.socesfar.es\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-4-2020\/"},"modified":"2021-10-18T08:42:45","modified_gmt":"2021-10-18T06:42:45","slug":"actualidad-en-farmacologia-y-terapeutica-vol-18-no-4-2020","status":"publish","type":"revista","link":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-4-2020\/","title":{"rendered":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 4, 2020"},"content":{"rendered":"\n<p><strong>Dolor y analg\u00e9sicos<br\/><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/AFTV18N4-WEB.pdf\">Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 4, 2020<\/a><\/strong><\/p>\n\n<h4 class=\"wp-block-heading\"><strong>\u00cdndice<\/strong><\/h4>\n\n<ul class=\"wp-block-list\"><li><strong>Editorial del Presidente.<\/strong> <a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/Editorial-del-presidente-La-Farmacologia-que-viene.pdf\">La Farmacolog\u00eda que viene<\/a><\/li><li><strong>Editorial del Director.<\/strong> <a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/Editorial-del-director-Aducamumab-y-alzheimer-Nueva-incertidumbre.pdf\">Aducamumab y alzheimer: \u00bfnueva incertidumbre?<\/a><\/li><li><strong>Editorial invitado.<\/strong> <a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/Editorial-invitado-vaccines-for-COVID-19-may-require-a-pharmacological-booster-in-elderly-populations.pdf\">\u00bfHacia d\u00f3nde va la inmunoterapia del c\u00e1ncer?<\/a> <a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/Editorial-invitado-vaccines-for-COVID-19-may-require-a-pharmacological-booster-in-elderly-populations.pdf\">Vaccines for COVID-19 may requiere a pharmacologic booster in elderly populations.<\/a><\/li><li><strong>Investigaci\u00f3n traslacional.<\/strong> <a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/La-epoxido-hidrolasa-soluble-una-nueva-diana-terapeutica.pdf\">La ep\u00f3xido hidrolasa soluble: \u00bfuna nueva diana terap\u00e9utica para el tratamiento de la enfermedad de Alzheimer?<\/a><\/li><li><strong>Revisiones en farmacoterapia<\/strong> <br\/><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/Dolor-y-analgesicos.pdf\">Dolor y analg\u00e9sicos<\/a>. <br\/><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/El-tratamiento-del-dolor-en-el-paciente-cirrotico.pdf\">El tratamiento del dolor en el paciente cirr\u00f3tico<\/a><\/li><li><strong>Cultura y f\u00e1rmacos<\/strong>:  <a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/Concretalizando.pdf\">Concretalizando&#8230;&#8221;<\/a><\/li><li><strong>Nuevas normas para los autores<\/strong><\/li><\/ul>","protected":false},"featured_media":0,"template":"","categoria_revista":[65],"class_list":["post-2669","revista","type-revista","status-publish","hentry","categoria_revista-2020-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 4, 2020 - Sociedad Espa\u00f1ola de Farmacolog\u00eda<\/title>\n<meta name=\"description\" content=\"Dolor y analg\u00e9sicos. Aducamumab y alzheimer: \u00bfnueva incertidumbre?. Actualidad en Farmacolog\u00eda y Terap\u00e9utica.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-4-2020\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 4, 2020 - Sociedad Espa\u00f1ola de Farmacolog\u00eda\" \/>\n<meta property=\"og:description\" content=\"Dolor y analg\u00e9sicos. Aducamumab y alzheimer: \u00bfnueva incertidumbre?. Actualidad en Farmacolog\u00eda y Terap\u00e9utica.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-4-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Socesfar\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-4-2020\\\/\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-4-2020\\\/\",\"name\":\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 4, 2020 - Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#website\"},\"datePublished\":\"2021-10-18T06:42:45+00:00\",\"description\":\"Dolor y analg\u00e9sicos. Aducamumab y alzheimer: \u00bfnueva incertidumbre?. Actualidad en Farmacolog\u00eda y Terap\u00e9utica.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-4-2020\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-4-2020\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-4-2020\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revistas\",\"item\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revistas\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 4, 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/\",\"name\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#organization\",\"name\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/logo-socesfar-02.png\",\"contentUrl\":\"https:\\\/\\\/www.socesfar.es\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/logo-socesfar-02.png\",\"width\":383,\"height\":63,\"caption\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\"},\"image\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/Socesfar\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/socesfar\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 4, 2020 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","description":"Dolor y analg\u00e9sicos. Aducamumab y alzheimer: \u00bfnueva incertidumbre?. Actualidad en Farmacolog\u00eda y Terap\u00e9utica.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-4-2020\/","og_locale":"en_US","og_type":"article","og_title":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 4, 2020 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","og_description":"Dolor y analg\u00e9sicos. Aducamumab y alzheimer: \u00bfnueva incertidumbre?. Actualidad en Farmacolog\u00eda y Terap\u00e9utica.","og_url":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-4-2020\/","og_site_name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","twitter_card":"summary_large_image","twitter_site":"@Socesfar","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-4-2020\/","url":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-4-2020\/","name":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 4, 2020 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","isPartOf":{"@id":"https:\/\/www.socesfar.es\/en\/#website"},"datePublished":"2021-10-18T06:42:45+00:00","description":"Dolor y analg\u00e9sicos. Aducamumab y alzheimer: \u00bfnueva incertidumbre?. Actualidad en Farmacolog\u00eda y Terap\u00e9utica.","breadcrumb":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-4-2020\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-4-2020\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-18-no-4-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.socesfar.es\/en\/"},{"@type":"ListItem","position":2,"name":"Revistas","item":"https:\/\/www.socesfar.es\/en\/revistas\/"},{"@type":"ListItem","position":3,"name":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 18, n\u00ba 4, 2020"}]},{"@type":"WebSite","@id":"https:\/\/www.socesfar.es\/en\/#website","url":"https:\/\/www.socesfar.es\/en\/","name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","description":"","publisher":{"@id":"https:\/\/www.socesfar.es\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.socesfar.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.socesfar.es\/en\/#organization","name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","url":"https:\/\/www.socesfar.es\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png","contentUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png","width":383,"height":63,"caption":"Sociedad Espa\u00f1ola de Farmacolog\u00eda"},"image":{"@id":"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/Socesfar","https:\/\/www.linkedin.com\/company\/socesfar\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/2669","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista"}],"about":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/types\/revista"}],"version-history":[{"count":1,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/2669\/revisions"}],"predecessor-version":[{"id":2670,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/2669\/revisions\/2670"}],"wp:attachment":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/media?parent=2669"}],"wp:term":[{"taxonomy":"categoria_revista","embeddable":true,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/categoria_revista?post=2669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}